MediFind
Condition

Urothelial Cancer

Latest Research

Latest Advance
Study
  • Condition: Miliary Pulmonary Tuberculosis
  • Journal: Revue medicale de Liege
  • Treatment Used: Intravesical Bacillus Calmette-Guerin (BCG) Instillation therapy
  • Number of Patients: 1
  • Published —
This case report describes a 74-year-old male who developed pulmonary granulomatosis secondary to intravesical Bacillus Calmette-Guerin (BCG) instillation therapy.
Latest Advance
Study
  • Condition: Patients with Renal Insufficiency and Mixed Variant Histology (MVH)
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Atezolizumab
  • Number of Patients: 218
  • Published —
This study reported the safety and effectiveness of atezolizumab in patients with renal insufficiency or urothelial carcinoma (UC) with mixed variant histology (MVH).
Latest Advance
Study
  • Condition: Advanced or Metastatic Urothelial Cancer
  • Journal: Anticancer research
  • Treatment Used: Second-Line Chemotherapy
  • Number of Patients: 25
  • Published —
This study assessed the effectiveness of second-line chemotherapy in patients with advanced or metastatic urothelial cancer.
Latest Advance
Study
  • Condition: Tumors
  • Journal: Annals of oncology : official journal of the European Society for Medical Oncology
  • Treatment Used: Nivolumab once every 4 weeks
  • Number of Patients: 3203
  • Published —
The study researched the effects of Nivolumab once every 4 weeks for many different types of tumors.
Latest Advance
Study
  • Condition: Advanced Solid Tumors
  • Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Treatment Used: Lenvatinib Plus Pembrolizumab
  • Number of Patients: 137
  • Published —
The study researched the outcomes of lenvatinib plus pembrolizumab in patients with advanced kidney cancer, endometrial cancer, and other advanced solid tumors.
Latest Advance
Study
  • Condition: Non-Metastatic Upper-Tract Urothelial Carcinoma
  • Journal: Saudi medical journal
  • Treatment Used: Laparoscopic or Open Nephroureterectomy
  • Number of Patients: 50
  • Published —
This study compared the clinical outcome of using a laparoscopic or open nephroureterectomy to treat patients with non-metastatic upper-tract urothelial carcinoma.
Latest Advance
Study
  • Condition: Ta and T1 Bladder Cancer
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Intravesical Bacillus Calmette-Guérin (BCG) vs. Mitomycin C (MMC)
  • Number of Patients: 2932
  • Published —
This review of the literature assessed the effects of Bacillus Calmette-Guérin (BCG) intravesical therapy compared to Mitomycin C (MMC) intravesical therapy for treating intermediate- and high-risk Ta and T1 bladder cancer in adults.
Latest Advance
Study
  • Condition: Patients with Solid Malignancies Treated with Immune Checkpoint Blockade (ICB)
  • Journal: Cancer immunology, immunotherapy : CII
  • Treatment Used: Antibiotics
  • Number of Patients: 2889
  • Published —
This review of the literature determined whether antibiotics affect overall survival (OS) and progression free survival (PFS) in patients with solid malignancies treated with immune checkpoint blockade (ICB).
Latest Advance
Study
  • Condition: High-Grade Upper Tract Urothelial Carcinoma (UTUC)
  • Journal: Annals of surgical oncology
  • Treatment Used: Neoadjuvant Chemotherapy (NAC)
  • Number of Patients: 48
  • Published —
This study evaluated the benefit of neoadjuvant chemotherapy (NAC) for survival in high-grade upper tract urothelial carcinoma (bladder cancer; UTUC).
Latest Advance
Study
  • Condition: Upper Urinary Tract Urothelial Carcinoma
  • Journal: BMC cancer
  • Treatment Used: Lymph Node Dissection after Nephroureterectomy
  • Number of Patients: 7278
  • Published —
This study tested the safety and efficacy of using a lymph node dissection to treat patients with upper urinary tract urothelial carcinoma after they had already undergone a nephroureterectomy.
Latest Advance
Study
  • Condition: Advanced or Metastatic Urothelial Carcinoma
  • Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
  • Treatment Used: Tremelimumab
  • Number of Patients: 32
  • Published —
This study reported on the effectiveness and safety of tremelimumab in patients with advanced or metastatic urothelial carcinoma.